Skip to main content

Advertisement

Log in

Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-α

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The objective of this study is to determine the effects of adrenomedullin (AM) on IL-1- and TNF-α-induced rheumatoid synovial fibroblasts (RASFs)-mediated osteoclastogenesis. The formation of osteoclasts in co-cultures of RASFs and peripheral blood mononuclear cells was evaluated by tartrate-resistant acid phosphatase and resorption pit formation assay. The expression of RANKL, OPG, p-ERK, p-p38, and p-JNK was examined by immunoblotting and quantitative reverse transcription-polymerase chain reaction. AM (1-52) inhibits IL-1- and TNF-α-induced RASFs-mediated osteoclastogenesis. AM affected IL-1-, TNF-α-induced RANKL and OPG expression in RASFs. AM also inhibits IL-1 and TNF-α-induced phosphorylation of ERK-1/2, p38 MAPK, and JNK. Inhibitor of AM (AM 22-52) inhibits the effects of AM on the osteoclastogenesis. These results suggest that AM might be involved in the inflammatory cytokines-mediated osteoclastogenesis and thus bone damage, and indicate that it can be a new therapeutic strategy against joint destruction in RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Cawston TE (1995) Proteinase and connective tissue breakdown. In: Henderson B, Edwards JCW, Pettipher ER (eds) Mechanisms and models in rheumatoid arthritis. Academic Press, London

    Google Scholar 

  2. Han MK, Kim JS, Park BH et al (2003) NF-kappaB-dependent lymphocyte hyperadhesiveness to synovial fibroblasts by hypoxia and reoxygenation: potential role in rheumatoid arthritis. J Leukoc Biol 73:525–529

    Article  PubMed  CAS  Google Scholar 

  3. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR (1998) Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943–951

    PubMed  CAS  Google Scholar 

  4. Lee HY, Jeon HS, Song EK et al (2006) CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis. Arthritis Rheum 54:1747–1758

    Article  PubMed  CAS  Google Scholar 

  5. Kong YY, Yoshida H, Sarosi I et al (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315–323

    Article  PubMed  CAS  Google Scholar 

  6. Goldring SR (2002) Bone and joint destruction in rheumatoid arthritis: what is really happening? J Rheumatol Suppl 65:44–48

    PubMed  CAS  Google Scholar 

  7. Romas E, Gillespie MT, Martin TJ (2002) Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30:340–346

    Article  PubMed  CAS  Google Scholar 

  8. Matsushita T, Matsui N, Yoshiya S, Fujioka H, Kurosaka M (2004) Production of adrenomedullin from synovial cells in rheumatoid arthritis patients. Rheumatol Int 24:20–24

    Article  PubMed  CAS  Google Scholar 

  9. Chosa E, Hamada H, Kitamura K, Eto T, Tajima N (2003) Increased plasma and joint tissue adrenomedullin concentrations in patients with rheumatoid arthritis compared to those with osteoarthritis. J Rheumatol 30:2553–2556

    PubMed  CAS  Google Scholar 

  10. Gonzalez-Rey E, Chorny A, O’Valle F, Delgado M (2007) Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells. Am J Pathol 170:263–271

    Article  PubMed  CAS  Google Scholar 

  11. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Article  PubMed  CAS  Google Scholar 

  12. Mbalaviele G, Nishimura R, Myoi A et al (1998) Cadherin-6 mediates the heterotypic interaction between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of osteoclast differentiation. J Cell Biol 141:1467–1476

    Article  PubMed  CAS  Google Scholar 

  13. Nanke Y, Kotake S, Yonemoto K, Saito S, Tomatsu T, Kamatani N (2003) Adrenomedullin in synovial fluids from patients with rheumatoid arthritis inhibits interleukin 6 production from synoviocytes. Ann Rheum Dis 62:82–83

    Article  PubMed  CAS  Google Scholar 

  14. Han Z, Boyle DL, Chang L et al (2001) c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108:73–81

    PubMed  CAS  Google Scholar 

  15. Badger AM, Griswold DE, Kapadia R et al (2000) Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum 43:175–183

    Article  PubMed  CAS  Google Scholar 

  16. Nishikawa M, Myoui A, Tomita T, Takahi K, Nampei A, Yoshikawa H (2003) Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis Rheum 48:2670–2681

    Article  PubMed  CAS  Google Scholar 

  17. McLatchie LM, Fraser NJ, Main MJ et al (1998) RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 393:333–339

    Article  PubMed  CAS  Google Scholar 

  18. Kobayashi K, Takahashi N, Jimi E et al (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275–285

    Article  PubMed  CAS  Google Scholar 

  19. Fuller K, Murphy C, Kirstein B, Fox SW, Chambers TJ (2002) TNF potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 143:1108–1118

    Article  PubMed  CAS  Google Scholar 

  20. Uzan B, Ea HK, Launay JM et al (2006) A critical role for adrenomedullin-calcitonin receptor-like receptor in regulating rheumatoid fibroblast-like synoviocyte apoptosis. J Immunol 176:5548–5558

    PubMed  CAS  Google Scholar 

  21. Nagaya N, Satoh T, Nishikimi T et al (2000) Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation 101:498–503

    PubMed  CAS  Google Scholar 

  22. Genovese MC, Kremer JM (2004) Treatment of rheumatoid arthritis with etanercept. Rheum Dis Clin North Am 30(2):311–328

    Article  PubMed  Google Scholar 

  23. Caramaschi P, Biasi D, Colombatti M et al (2006) Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity. Rheumatol Int 26(3):209–214

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

“The work was supported by Korea Research Foundation Grant (KRF-2007-314-E00111) and the Fund of Chonbuk National University Hospital Research Institute of Clinical Medicine.”

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wan-Hee Yoo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yun, HJ., Lee, EG., Lee, SI. et al. Adrenomedullin inhibits MAPK pathway-dependent rheumatoid synovial fibroblast-mediated osteoclastogenesis by IL-1 and TNF-α. Rheumatol Int 29, 1161–1168 (2009). https://doi.org/10.1007/s00296-008-0832-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-008-0832-0

Keywords

Navigation